|
|
ossification
|
GO:0001503 |
216 |
0.874
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.574
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.553
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.475
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.474
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.431
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.378
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.358
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.345
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.337
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.331
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.311
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.294
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.274
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.269
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.268
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.253
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.252
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.244
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.233
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.227
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.224
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.218
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.208
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.206
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.194
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.193
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.187
|
Worm |
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.185
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.180
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.178
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.175
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.175
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.174
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.170
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.161
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.160
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.158
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.153
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.148
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.147
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.146
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.146
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.145
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.144
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.143
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.142
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.141
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.140
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.136
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.135
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.132
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.132
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.132
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.131
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.130
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.130
|
|
|
|
nucleoside bisphosphate biosynthetic process
|
GO:0033866 |
6 |
0.127
|
|
|
|
trophectodermal cellular morphogenesis
|
GO:0001831 |
3 |
0.126
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.124
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.124
|
|
|
|
sulfate assimilation
|
GO:0000103 |
3 |
0.121
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.121
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.120
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.120
|
|
|
|
axial mesodermal cell fate specification
|
GO:0048327 |
1 |
0.118
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.117
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.115
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.115
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.114
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.113
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.113
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.113
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.112
|
|
|
|
negative regulation of planar cell polarity pathway involved in pericardium morphogenesis
|
GO:2000166 |
1 |
0.112
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.112
|
|
|
|
morphogenesis of an epithelial fold
|
GO:0060571 |
28 |
0.111
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.111
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.110
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.110
|
|
|
|
regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000148 |
1 |
0.108
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.108
|
|
|
|
ribonucleoside bisphosphate metabolic process
|
GO:0033875 |
9 |
0.107
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.106
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.105
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.103
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.096
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.096
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.095
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.095
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.095
|
|
|
|
negative regulation of kidney development
|
GO:0090185 |
15 |
0.094
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.094
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.094
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.093
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.091
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.090
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.090
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.089
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.089
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.089
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.089
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.088
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.088
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.088
|
|
|
|
branching involved in salivary gland morphogenesis
|
GO:0060445 |
26 |
0.087
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.087
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.087
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.086
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.085
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.085
|
|
|
|
floor plate morphogenesis
|
GO:0033505 |
3 |
0.083
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.083
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.083
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.083
|
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.082
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.082
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.081
|
|
|
|
vagus nerve morphogenesis
|
GO:0021644 |
2 |
0.081
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.081
|
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
2 |
0.079
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.077
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.076
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.076
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.076
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.074
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.074
|
|
|
|
prostate epithelial cord elongation
|
GO:0060523 |
3 |
0.073
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.073
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.072
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.072
|
|
|
|
prostate gland morphogenetic growth
|
GO:0060737 |
4 |
0.072
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.072
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.072
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.071
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.071
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.070
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.070
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.069
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.069
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.069
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.069
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.069
|
|
|
|
mammary placode formation
|
GO:0060596 |
4 |
0.068
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.068
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.068
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.067
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.067
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.066
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.066
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.066
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.065
|
|
|
|
negative regulation of planar cell polarity pathway involved in heart morphogenesis
|
GO:2000160 |
1 |
0.065
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.065
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.064
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.064
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.064
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.063
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.063
|
|
|
|
anterior commissure morphogenesis
|
GO:0021960 |
6 |
0.062
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.062
|
|
|
|
substantia nigra development
|
GO:0021762 |
2 |
0.062
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.062
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.062
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.062
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.062
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.062
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.061
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.061
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072040 |
4 |
0.061
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.060
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.060
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.059
|
|
|
|
nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900164 |
2 |
0.058
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.058
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.058
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.057
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.057
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.057
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.056
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.056
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.056
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.056
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.055
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.055
|
|
|
|
mammary gland bud morphogenesis
|
GO:0060648 |
4 |
0.055
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.054
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.054
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.054
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.054
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.053
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.053
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.053
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.052
|
|
|
|
mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:1901145 |
4 |
0.052
|
|
|
|
axial mesodermal cell fate commitment
|
GO:0048322 |
1 |
0.052
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.051
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.051
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.051
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.051
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.051
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.051
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.051
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.051
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.051
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.050
|
|
|
|
regulation of protein geranylgeranylation
|
GO:2000539 |
2 |
0.050
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.049
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.049
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.049
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.048
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.048
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.048
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.048
|
|
|
|
cellular response to cholesterol
|
GO:0071397 |
2 |
0.048
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.048
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.048
|
|
|
|
extracellular matrix assembly
|
GO:0085029 |
12 |
0.047
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.047
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.047
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.047
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.046
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.046
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.046
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.046
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.045
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.045
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.045
|
|
|
|
transforming growth factor beta receptor signaling pathway involved in primitive streak formation
|
GO:0090010 |
1 |
0.045
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.045
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.045
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.045
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.045
|
|
|
|
negative regulation of chondrocyte differentiation
|
GO:0032331 |
13 |
0.045
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.045
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.044
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.044
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.044
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.044
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.043
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.043
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.043
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.043
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.043
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.043
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.043
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.043
|
|
|
|
mammary gland bud formation
|
GO:0060615 |
2 |
0.043
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.043
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.043
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.042
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.042
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.042
|
|
|
|
signal transduction downstream of smoothened
|
GO:0007227 |
4 |
0.042
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.042
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.042
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.042
|
|
|
|
divalent inorganic anion homeostasis
|
GO:0072505 |
5 |
0.042
|
|
|
|
epithelial cell proliferation involved in prostate gland development
|
GO:0060767 |
11 |
0.041
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.041
|
|
|
|
regulation of cell proliferation in bone marrow
|
GO:0071863 |
2 |
0.041
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.041
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.041
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.041
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.041
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.040
|
|
|
|
memory
|
GO:0007613 |
58 |
0.040
|
|
|
|
regulation of planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:2000163 |
1 |
0.040
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.040
|
|
|
|
response to cholesterol
|
GO:0070723 |
4 |
0.040
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.039
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.039
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.039
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.039
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.039
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.039
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.039
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.038
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.038
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.038
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.038
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.038
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.037
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.037
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.037
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.037
|
|
|
|
defense response to gram negative bacterium
|
GO:0050829 |
28 |
0.037
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.037
|
|
|
|
metanephric mesenchymal cell proliferation involved in metanephros development
|
GO:0072136 |
2 |
0.036
|
|
|
|
astrocyte activation
|
GO:0048143 |
2 |
0.036
|
|
|
|
positive regulation of heart growth
|
GO:0060421 |
18 |
0.036
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.036
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.036
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.036
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.036
|
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.036
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.036
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.036
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.036
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.036
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.035
|
|
|
|
mammary gland specification
|
GO:0060594 |
4 |
0.035
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.035
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.035
|
|
|
|
apoptotic process in bone marrow
|
GO:0071839 |
1 |
0.035
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.035
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.035
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.035
|
|
|
|
positive regulation of endothelial cell proliferation
|
GO:0001938 |
17 |
0.035
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.034
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.034
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.034
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.034
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.034
|
|
|
|
protein geranylgeranylation
|
GO:0018344 |
3 |
0.034
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.034
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.034
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
44 |
0.034
|
|
|
|
orbitofrontal cortex development
|
GO:0021769 |
2 |
0.034
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.033
|
|
|
|
regulation of smooth muscle cell differentiation
|
GO:0051150 |
9 |
0.033
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.033
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.033
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.033
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.033
|
|
|
|
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis
|
GO:0060527 |
7 |
0.033
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.033
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.033
|
|
|
|
positive regulation of skeletal muscle cell differentiation
|
GO:2001016 |
4 |
0.033
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.033
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.033
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.033
|
|
|
|
branch elongation involved in salivary gland morphogenesis
|
GO:0060667 |
2 |
0.032
|
|
|
|
astrocyte cell migration
|
GO:0043615 |
3 |
0.032
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.032
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.032
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.032
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.032
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.032
|
|
|
|
negative regulation of stem cell maintenance
|
GO:1902455 |
4 |
0.032
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.032
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
35 |
0.031
|
|
|
|
embryonic skeletal joint development
|
GO:0072498 |
13 |
0.031
|
|
|
|
forebrain regionalization
|
GO:0021871 |
25 |
0.031
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.031
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.031
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.031
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.031
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.031
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.031
|
|
|
|
peptidyl proline hydroxylation
|
GO:0019511 |
3 |
0.031
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.031
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.030
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.030
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.030
|
|
|
|
negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:2000164 |
1 |
0.030
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.030
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.030
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.030
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.030
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.030
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.030
|
|
|
|
negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:2000162 |
1 |
0.030
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.030
|
|
|
|
regulation of cardiac chamber morphogenesis
|
GO:1901219 |
2 |
0.030
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.030
|
|
|
|
lung saccule development
|
GO:0060430 |
7 |
0.029
|
|
|
|
positive regulation of hh target transcription factor activity
|
GO:0007228 |
3 |
0.029
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.029
|
|
|
|
mesenchymal cell differentiation involved in lung development
|
GO:0060915 |
2 |
0.029
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.029
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.029
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.029
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.029
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.029
|
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.028
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.028
|
|
|
|
ventral midline development
|
GO:0007418 |
4 |
0.028
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.028
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.028
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.028
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.028
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.028
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.028
|
|
|
|
negative regulation of cartilage development
|
GO:0061037 |
17 |
0.028
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.028
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.027
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.027
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.027
|
|
|
|
ventricular zone neuroblast division
|
GO:0021847 |
3 |
0.027
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.027
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.027
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.027
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.027
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
23 |
0.027
|
|
|
|
thymic t cell selection
|
GO:0045061 |
22 |
0.027
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.027
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.027
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.026
|
|
|
|
regulation of mesenchymal cell proliferation involved in ureter development
|
GO:0072199 |
3 |
0.026
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.026
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.026
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.026
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.026
|
|
|
|
negative regulation of smooth muscle cell migration
|
GO:0014912 |
2 |
0.026
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.026
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.026
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.026
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.026
|
|
|
|
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation
|
GO:0021938 |
4 |
0.026
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.026
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.026
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.026
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.026
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.026
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.026
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.026
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.026
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.026
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.026
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.025
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.025
|
|
|
|
nucleoside bisphosphate metabolic process
|
GO:0033865 |
9 |
0.025
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.025
|
|
|
|
negative regulation of lymphocyte differentiation
|
GO:0045620 |
32 |
0.025
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.025
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.025
|
|
|
|
multicellular organismal catabolic process
|
GO:0044243 |
7 |
0.025
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.025
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.025
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.025
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.024
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.024
|
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.024
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.024
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.024
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.024
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.024
|
|
|
|
positive regulation of smooth muscle cell differentiation
|
GO:0051152 |
2 |
0.024
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.024
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.024
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.024
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.024
|
|
|
|
male genitalia development
|
GO:0030539 |
20 |
0.024
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.024
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.024
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.024
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.024
|
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
30 |
0.024
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.024
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.024
|
|
|
|
ascending aorta morphogenesis
|
GO:0035910 |
3 |
0.023
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.023
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.023
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.023
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.023
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.023
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.023
|
|
|
|
lung lobe morphogenesis
|
GO:0060463 |
9 |
0.023
|
|
|
|
substrate dependent cerebral cortex tangential migration
|
GO:0021825 |
3 |
0.023
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.023
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.023
|
Human |
|
|
humoral immune response
|
GO:0006959 |
57 |
0.023
|
|
|
|
organ maturation
|
GO:0048799 |
17 |
0.023
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry
|
GO:1900094 |
2 |
0.023
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.023
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.023
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.023
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.023
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
31 |
0.023
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.022
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.022
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.022
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.022
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.022
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.022
|
|
|
|
epithelial cell differentiation involved in kidney development
|
GO:0035850 |
23 |
0.022
|
|
|
|
positive regulation of protein import into nucleus
|
GO:0042307 |
26 |
0.022
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.022
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.022
|
|
|
|
cellular response to fluid shear stress
|
GO:0071498 |
4 |
0.022
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.022
|
|
|
|
canonical wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development
|
GO:0061310 |
1 |
0.022
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.022
|
|
|
|
regulation of transcription factor import into nucleus
|
GO:0042990 |
24 |
0.022
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.022
|
|
|
|
lateral mesoderm morphogenesis
|
GO:0048369 |
3 |
0.022
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.022
|
|
